Ramsay Health Care Limited's 2026 Half Year Results Presentation highlighted a 7.3% increase in Group underlying EBIT, with revenue growing by 9.7% to $9.3 billion. Australian operations saw strong growth, contributing significantly to these results. Ramsay Santé showed improvement, while the UK division faced NHS budget constraints. The company is progressing with key developments such as the Joondalup Hospital expansion, maintaining leverage within target levels. Capital expenditure is focused on expanding capacity in Australia, with overall spending expected to be lower than previously forecasted. Cost management and strategic focus on operational excellence were emphasized across the group.
Key Points
Ramsay Health Care Limited reported a 7.3% increase in Group underlying EBIT for the first half of the 2026 financial year.
The Group's revenue grew by 9.7% compared to the first half of FY25, totaling $9.3 billion.
Australian operations saw a 7.1% increase in EBIT, driven by increased activity and higher revenue indexation.
Ramsay Santé's performance showed improvement with a 14.2% rise in underlying EBIT.
The Group completed significant developments, including the Joondalup Private Hospital expansion.
The Funding Group maintained a leverage ratio of 2.22x, within its target range.
Capital expenditure for FY26 is expected to be between $755-795 million, focusing on procedural capacity in Australia.
Ramsay UK faced challenges due to NHS budget constraints, but the company expects to benefit from additional future funding.
Elysium's turnaround is progressing with cost reduction and site optimization efforts underway.
Net financing expenses are forecasted to be $590-610 million for the fiscal year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.